Arginine early after heart surgery to prevent kidney injury
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether giving the amino acid L-arginine soon after heart surgery can help prevent acute kidney injury (a sudden drop in kidney function). If you're recovering in the ICU after heart surgery, this may help protect your kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult who is admitted to the intensive care unit (ICU) after heart surgery using a heart-lung machine.
- You do not have a heart condition you were born with (congenital heart disease).
- Your heart surgery did not require deep hypothermic circulatory arrest (a very low body temperature technique).
- Your kidney function before surgery was not severely low (estimated filtration rate at least 30 mL/min/1.73 m²).
- You did not already have acute kidney injury before entering the ICU.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving amino acids (protein building blocks) during heart surgery can help protect your kidneys from damage. If you are having heart surgery and are at high risk, this treatment might reduce the chance of kidney problems afterward.
This trial is testing whether giving amino acids after heart surgery can help prevent kidney injury in children at high risk. If it works, it could offer a simple way to protect kidney function during recovery.
This study tests whether giving amino acids (the building blocks of protein) through an IV during heart surgery can help protect your kidneys. It is for people having planned heart surgery and staying in the ICU afterward.
This study looks at a protein in the blood that may help predict kidney damage after heart surgery. It aims to find ways to protect kidney function during and after the operation.
This trial looks at whether a specific heart-surgery technique (called CLCVP) can help protect kidney function soon after surgery. It is mainly for adults with otherwise normal kidney tests before certain types of heart operations.
This Phase 2 trial tests an LSALT peptide given around the time of “on-pump” heart surgery to help prevent or reduce acute kidney injury (a sudden drop in kidney function). It may help people who are at higher risk for kidney injury during or after surgery.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.